Orogen Royalties Inc
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2020-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.organon.com
- Introduction
Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.
Preference for Clarinex Tablets vs Allegra Tablets in Patients With Seasonal Allergies (P03178)
Phase 4
Completed
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- First Posted Date
- 2008-11-20
- Last Posted Date
- 2022-02-17
- Lead Sponsor
- Organon and Co
- Target Recruit Count
- 118
- Registration Number
- NCT00794768
Taste Test Between Desloratadine and Cetirizine Syrup in Children (Study P03826)
Phase 3
Completed
- Conditions
- Allergic Rhinitis
- Interventions
- First Posted Date
- 2008-11-20
- Last Posted Date
- 2022-02-16
- Lead Sponsor
- Organon and Co
- Target Recruit Count
- 204
- Registration Number
- NCT00794794
Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03180)
Phase 4
Completed
- Conditions
- Seasonal Allergic RhinitisPerennial Allergic Rhinitis
- Interventions
- First Posted Date
- 2008-11-20
- Last Posted Date
- 2022-02-17
- Lead Sponsor
- Organon and Co
- Target Recruit Count
- 124
- Registration Number
- NCT00794846
Taste Test Between Desloratadine and Cetirizine Syrup in Children (Study P03829)(COMPLETED)
Phase 3
Completed
- Conditions
- Allergic Rhinitis
- Interventions
- First Posted Date
- 2008-11-20
- Last Posted Date
- 2022-02-16
- Lead Sponsor
- Organon and Co
- Target Recruit Count
- 202
- Registration Number
- NCT00794378
Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03182)
Phase 4
Completed
- Conditions
- Perennial Allergic RhinitisSeasonal Allergic Rhinitis
- Interventions
- First Posted Date
- 2008-11-20
- Last Posted Date
- 2022-02-17
- Lead Sponsor
- Organon and Co
- Target Recruit Count
- 118
- Registration Number
- NCT00794599
Preference for Clarinex Tablets vs. Allegra Tablets in Patients With Seasonal Allergies (Study P03179)
Phase 4
Completed
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- First Posted Date
- 2008-11-20
- Last Posted Date
- 2022-02-17
- Lead Sponsor
- Organon and Co
- Target Recruit Count
- 122
- Registration Number
- NCT00794248
A Study of MK0663/Etoricoxib for Post-Abdominal Hysterectomy Surgery Pain (0663-097)(COMPLETED)
Phase 3
Completed
- Conditions
- Acute Pain Following a Total Abdominal Hysterectomy
- Interventions
- First Posted Date
- 2008-11-11
- Last Posted Date
- 2022-02-09
- Lead Sponsor
- Organon and Co
- Target Recruit Count
- 430
- Registration Number
- NCT00788710
The Effect of Desloratadine and Levocetirizine on Nasal Obstruction (Study P03609)
- First Posted Date
- 2008-11-11
- Last Posted Date
- 2024-08-15
- Lead Sponsor
- Organon and Co
- Target Recruit Count
- 81
- Registration Number
- NCT00789152
A Comparative Study of Mometasone Furoate Nasal Spray and Fluticasone Propionate Nasal Spray in Patients With Perennial Allergic Rhinitis (Study P04512)
Phase 3
Completed
- Conditions
- Perennial Allergic Rhinitis
- Interventions
- First Posted Date
- 2008-10-31
- Last Posted Date
- 2022-02-09
- Lead Sponsor
- Organon and Co
- Target Recruit Count
- 351
- Registration Number
- NCT00783224
A Study of Ezetimibe Added On to Rosuvastatin Versus Up Titration of Rosuvastatin in Patients With Hypercholesterolemia (MK0653-139)
Phase 3
Completed
- Conditions
- Hypercholesterolemia
- First Posted Date
- 2008-10-31
- Last Posted Date
- 2024-05-14
- Lead Sponsor
- Organon and Co
- Target Recruit Count
- 440
- Registration Number
- NCT00783263